Sorafenib Tosylate Powder CAS 475207-59-1 Sorafenib Tosylate Purity Sorafenib Tosylate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• CAS: 475207-59-1
• Keyword: Sorafenib Tosylate
• Keyword 1: Sorafenib Tosylate Powder
• Transport Package: 1kg Foil Bag /25kg Drum
• Specification: 99%
• Trademark: /
• Origin: China
• Production Capacity: 20000

Product Description

Product Description

Description

Sorafenib is a new multi-targeted oral drug for the treatment of tumors. Its primary development goal is to treat gastrointestinal stromal tumors and metastatic kidney cells that are not responsive or unbearable to standard therapies.

Sorafenib can selectively target certain proteins of the receptor, which is considered plays a role in molecular switching in the tumor growth process.

Product name	Sorafenib Tosylate
Appearance	white Powder
Specification	99%
Shelf life	2 years when properly stored

Function and Application

1. Sorafenib tosylate is commonly used as a potent RAF kinase inhibitor.

2. Sorafenib tosylate is also used as antineoplastic drug.

3. Sorafenib is used to treat liver tumor cells that can not be surgically or distantly metastasized

4. Sorafenib is used to treat neovascular tumors that can not be operated

5. Sorafenib is used to treat radioactive iodine therapy is no longer effective local recurrence or metastasis, progressive differentiation of thyroid patients.